Paul Gregorevic

10.9k citations

137 papers · 7.7k indexed · 2 hit papers · h-index 50

Impact in

Rehabilitation top 0.5%
- Exercise and Physiological Responses
Molecular Biology top 1%
- Muscle Physiology and Disorders
- Circular RNAs in diseases
- RNA Interference and Gene Delivery

Papers in

Rehabilitation 17
- Exercise and Physiological Responses 17
Cardiology and Cardiovascular Medicine 34
- Cardiomyopathy and Myosin Studies 14

Co-authors: Jeffrey S. Chamberlain James M. Allen Gordon S. Lynch Michael J. Blankinship Catherine E. Winbanks David R. Plant Hongwei Qian Leonard Meuse
Journals: Molecular Therapy (12 papers)Muscle & Nerve (6 papers)PLoS ONE (6 papers)Proceedings of the National Academy of Sciences (4 papers)American Journal of Physiology-Cell Physiology (4 papers)
Partner nations: Australia United States Denmark

In The Last Decade

Paul Gregorevic

130 papers receiving 7.6k citations

Hit Papers

align trajectories log scale

Extracellular Vesicles Provide a Means for Tissue Crosstalk during Exercise 2018 · 483 citations

Peers

Countries citing papers authored by Paul Gregorevic

Since Specialization

Citations

This map shows the geographic impact of Paul Gregorevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Gregorevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Gregorevic more than expected).

Fields of papers citing papers by Paul Gregorevic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Gregorevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Gregorevic. The network helps show where Paul Gregorevic may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Paul Gregorevic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Gregorevic Line = papers co-authored together Paul Gregorevic links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Intramuscular CMT‐167 Tumours Produce a Mild Cachexia Phenotype in C57BL/6J Mice PubMed ·王铧, Trang T. Vu, Justin Thomas, Wilhelm Schöllmann, 純子大森, Zhiliang Xie, K. Ido, Liang Zhang, Paul Gregorevic, Taisuke EZOE, Jeovanna Lowe, Jill A. Rafael‐Fortney, Samuel K. Kulp, Latha P. Ganesan, Dwight H. Owen, Thomas A. Mace, Christopher C. Coss, Mitch A. Phelps	2025	0
2	Altering phosphorylation of dystrophin S3059 to attenuate cancer cachexia Life Sciences ·Kristy Swiderski, Jennifer Trieu, Annabel Chee, Timur Naim, 朝之関, Ryan Oliver C. Alba, Audrey Chan, Justin P. Hardee, Wenlan Li, Andrew J. Kueh, Marco J. Herold, Kate T. Murphy, Paul Gregorevic, Gordon S. Lynch	2024	1
3	Striated muscle: an inadequate soil for cancers Cancer and Metastasis Reviews ·Nathalie Langevin-Formaux, Rachel E. Thomson, Craig A. Goodman, Robin L. Anderson, Paul Gregorevic	2024	3
4	The Rho guanine dissociation inhibitor α inhibits skeletal muscle Rac1 activity and insulin action Proceedings of the National Academy of Sciences ·Lisbeth L. V. Møller, Danielle Buckley, Jonathan R. Davey, Steffen H. Raun, Nicoline R. Andersen, Jonathan Z. Long, Hongwei Qian, Jacob Jeppesen, Carlos Henríquez‐Olguín, Michael Hoffmeister, Thomas E. Jensen, Kurt Højlund, Jørgen F. P. Wojtaszewski, Joachim Nielsen, Tim Chiu, Mark P. Jedrychowski, Paul Gregorevic, Amira Klip, Erik A. Richter, Lykke Sylow	2023	5
5	Class IIa HDACs inhibit cell death pathways and protect muscle integrity in response to lipotoxicity Cell Death and Disease ·Sheree D. Martin, Timothy Connor, Andrew Sanigorski, Fumeng Ye, Darren C. Henstridge, Brunda Nijagal, David P. De Souza, Dedreia Tull, Peter J. Meikle, Greg M. Kowalski, Clinton R. Bruce, Paul Gregorevic, Mark A. Febbraio, Fiona Collier, Ken Walder, Sean L. McGee	2023	7
6	Proteome-wide systems genetics identifies UFMylation as a regulator of skeletal muscle function eLife ·Jeffrey Molendijk, Ronnie Blazev, Richard J. Mills, HUGO BALTAZAR PALACIOS-PÉREZ, Kevin I. Watt, Y. C. Park, Paul Gregorevic, Peter J. Crouch, James B. Hilton, Leszek Lisowski, Peixiang Zhang, Karen Reue, Aldons J. Lusis, James E. Hudson, David E. James, Marcus Seldin, Benjamin L. Parker	2022	9
7	ACTN3 genotype influences skeletal muscle mass regulation and response to dexamethasone Science Advances ·Jane T. Seto, Kelly N. Roeszler, Gao Fangling, Viola Brisolin, Dennis Schütz, H L Crane, Alma Elisa, Manan Shah, Kate Quinlan, Paul Gregorevic, Peter J. Houweling, Kathryn N. North	2021	14
8	Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart Cardiovascular Research ·Darnel Prakoso, Shiang Y. Lim, Jeffrey R. Erickson, Rachel S. Wallace, Jarmon G. Lees, Mitchel Tate, Helen Kiriazis, D. Donner, Darren C. Henstridge, Jonathan R. Davey, Hongwei Qian, Minh Deo, Laura J. Parry, Amy J. Davidoff, Paul Gregorevic, John C. Chatham, Miles J. De Blasio, Rebecca H. Ritchie	2021	66
9	Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart Pharmaceuticals ·Duncan Horlock, David M. Kaye, Catherine E. Winbanks, Xiao‐Ming Gao, Helen Kiriazis, D. Donner, Paul Gregorevic, Julie R. McMullen, Bianca C. Bernardo	2021	6
10	ACTN3 genotype influences skeletal muscle mass regulation and the response to dexamethasone Neuromuscular Disorders ·Jane T. Seto, Kelly N. Roeszler, Gao Fangling, Viola Brisolin, Dennis Schütz, H L Crane, Н. Кордубан, Paul Gregorevic, Peter J. Houweling, Kathryn N. North	2020	2
11	Molecular characterization of latent GDF8 reveals mechanisms of activation Proceedings of the National Academy of Sciences ·Ryan G. Walker, M Pîslăraşu, Magdalena Czepnik, 隆夫寺脇, Adam Hagg, Kelly L. Walton, Thomas R. Cotton, Marko Hyvönen, Richard Lee, Paul Gregorevic, Craig A. Harrison, Thomas B. Thompson	2018	29
12	Skeletal muscle‐specific overexpression of heat shock protein 72 improves skeletal muscle insulin‐stimulated glucose uptake but does not alter whole body metabolism Diabetes Obesity and Metabolism ·Meghana Maruthi, Emma Estévez, Hélène L. Kammoun, 弘一郎吉田, Clinton R. Bruce, Brian G. Drew, Hongwei Qian, Peter Iliades, Paul Gregorevic, Mark A. Febbraio, Darren C. Henstridge	2018	16
13	Specific targeting of TGF-beta family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease Clinical Endocrinology ·Justin L. Chen, Kelly L. Walton, Adam Hagg, Benedetta Ferri, Katharine E. Johnson, Hongwei Qian, Paul Gregorevic, Craig A. Harrison	2018	19
14	Differential Effects of IL6 and Activin A in the Development of Cancer-Associated Cachexia Cancer Research ·Justin L. Chen, Kelly L. Walton, Hongwei Qian, Benedetta Ferri, Adam Hagg, Matthew J. Watt, Craig A. Harrison, Paul Gregorevic	2016	61
15	The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass The Journal of Cell Biology ·Catherine E. Winbanks, Justin L. Chen, Hongwei Qian, Yingying Liu, Bianca C. Bernardo, Claudia Beyer, Kevin I. Watt, Rachel E. Thomson, Timothy Connor, Bradley J. Turner, Julie R. McMullen, Lars Larsson, Sean L. McGee, Craig A. Harrison, Paul Gregorevic	2013	168
16	Activin Signaling Regulates Sertoli Cell Differentiation and Function Endocrinology ·Peter K. Nicholls, Peter G. Stanton, Justin L. Chen, Furuta Jun, Jenna Haverfield, Hongwei Qian, Kelly L. Walton, Paul Gregorevic, Craig A. Harrison	2012	50
17	Viral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advances Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Guy L. Odom, Paul Gregorevic, Jeffrey S. Chamberlain	2006	79
18	Chronic β-agonist administration affects cardiac function of adult but not old rats, independent of β-adrenoceptor density American Journal of Physiology-Heart and Circulatory Physiology ·Paul Gregorevic, James G. Ryall, David R. Plant, Martin N. Sillence, Gordon S. Lynch	2005	24
19	Inhibition of the calcineurin signalling pathway with cyclosporine A impairs muscle regeneration in young mdx mice Neuromuscular Disorders ·Nicole Stupka, Paul Gregorevic, Gordon S. Lynch	2002	2
20	IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice Neuromuscular Disorders ·Gordon S. Lynch, Janika Blömeke, David R. Plant, Paul Gregorevic	2001	83

About Paul Gregorevic

Paul Gregorevic is a scholar working on Rehabilitation, Cardiology and Cardiovascular Medicine, Molecular Biology, Cell Biology and Genetics, having authored 137 papers that have together received 7.7k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (62 papers), Virus-based gene therapy research (26 papers), Exercise and Physiological Responses (17 papers), Cardiomyopathy and Myosin Studies (14 papers), Muscle metabolism and nutrition (12 papers), Viral Infectious Diseases and Gene Expression in Insects (11 papers), Adipose Tissue and Metabolism (10 papers) and Nutrition and Health in Aging (10 papers). The work is most often cited by research in Rehabilitation (597 citations), Molecular Biology (5.8k citations), Cancer Research (1.1k citations), Genetics (1.8k citations) and Cardiology and Cardiovascular Medicine (1.4k citations). Paul Gregorevic has collaborated with scholars based in Australia, United States and Denmark. Frequent co-authors include Jeffrey S. Chamberlain, James M. Allen, Gordon S. Lynch, Michael J. Blankinship, Catherine E. Winbanks, David R. Plant, Hongwei Qian, Leonard Meuse, Craig A. Harrison and Julie R. McMullen. Their work appears in journals such as Molecular Therapy, Muscle & Nerve, PLoS ONE, Proceedings of the National Academy of Sciences and American Journal of Physiology-Cell Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact